FDA Inspection 1204764 — Marta Wilkowska-Trojniel, MD, PhD

Marta Wilkowska-Trojniel, MD, PhD — FEI 3025905703

The FDA completed an inspection of Marta Wilkowska-Trojniel, MD, PhD on March 31, 2023 in Bialystok. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 31, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bialystok (Poland)

Additional Details

Clinical Investigator (CI)